Clinical Trials Logo

Clinical Trial Summary

This study aims to determine the effectiveness of prophylactic antibiotic use for TACE and occurrence of postoperative liver abscess. There would be two comparison groups. Current standard of care treatment at PKLI&RC (as per local guidelines) would be given to all patients receiving TACE for the intervention group or 'antibiotic group' (i.e., Inj. Ceftriaxone 1g, intravenous × stat). While no antibiotic would be given to the 'no antibiotic group'.


Clinical Trial Description

Liver cancer especially hepatocellular carcinoma (HCC) is among the top five most common carcinomas in the world. According to the latest Cardiovascular and Interventional Radiological Society of Europe (CIRSE) standards of practice guidelines (2021), routine antibiotic prophylaxis is not recommended. However, prophylactic antibiotics are recommended in cases where there is a high risk of developing a liver abscess. These include biliary obstruction or the presence of a bilioenteric anastomosis. This study aims to determine the effectiveness of prophylactic antibiotic use for TACE and occurrence of postoperative liver abscess. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05654896
Study type Interventional
Source Pakistan Kidney and Liver Institute and Research Center
Contact Ahmad Zia Ud Din, MBBS, FRCR
Phone +923028099040
Email ahmad.zia@pkli.org.pk
Status Recruiting
Phase Phase 3
Start date November 26, 2022
Completion date December 26, 2023

See also
  Status Clinical Trial Phase
Terminated NCT03028129 - Prevention of Tuberculosis in Prisons Phase 4
Completed NCT05612542 - Pediatric Cardiac Surgery Comparing Short 24-hour Antibiotic Prophylaxis to Extended Antibiotic Prophylaxis
Completed NCT03765645 - Comparison of 9 Doses vs 3 Doses of Post Operative Antibiotics in Live Liver Donors N/A
Completed NCT03306290 - Serum Concentration of CEFOxitin Used for Antibiotic Prophylaxis in Obese Patients Undergoing BARiatric Surgery N/A
Recruiting NCT03283878 - Antibiotic Prophylaxis in Patients Undergoing Elective TKA- Multi-center Trial Phase 4
Not yet recruiting NCT05438082 - Antibiotic Prophylaxis to Prevent Post-procedure UTI After VCUG Phase 4
Recruiting NCT05609240 - Colo-Pro_2: Bolus-continuous Infusion Cefuroxime Prophylaxis for the Prevention of Infections After Colorectal Surgery Phase 2
Withdrawn NCT04280237 - Pharmacological Study of Cefazolin Antibioprophylaxis in Liver Transplantation
Completed NCT02479503 - Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey
Completed NCT00818766 - Efficacy of Post-operative Antibiotic Prophylaxis for Thoracic Surgery Requiring Tube Thoracostomy. N/A
Recruiting NCT05755789 - Intermittent Cefoxitin Administration Versus Loading Bolus Followed by Continuous Infusion for the Prevention of Surgical Site Infection in Colorectal Surgery Phase 3
Withdrawn NCT01880112 - Serum and Tissue Cefazolin Concentrations in Normal Weight Patients Undergoing Cesarean Delivery. Phase 4
Withdrawn NCT03982810 - The Role of Guideline-adherent Perioperative Antibiotic Administration and the Risk of Surgical Site Infections After Non-cardiac Surgery.
Recruiting NCT03269604 - Effectiveness of Three Times of Starting Antibiotic Prophylaxis in Patients With Asymptomatic Bacteriuria. N/A
Terminated NCT03386227 - Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT N/A
Completed NCT02809729 - Antibiotic Prophylaxis in Oncological Surgery of Breast N/A
Completed NCT03412305 - The Effect of Antibiotic Prophylaxis Associated With Dental Implant Surgery Phase 4
Completed NCT03790254 - D Mannose for Prevention and Treatment of RUTIs
Recruiting NCT05519072 - Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA Phase 4
Not yet recruiting NCT05813184 - Prenatal Antibiotics and Breast Milk / Neonatal IgA